McElhenny Sheffield Capital Management’s Amgen AMGN Stock Holding History

McElhenny Sheffield Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,117	Closed	-$597K	–	101
2025 Q3	$597K	Buy	2,117 +104	+5%	+$30.2K	0.14%	38
2025 Q2	$562K	Sell	2,013 -124	-6%	-$35.1K	0.15%	39
2025 Q1	$666K	Sell	2,137 -1	-0%	-$295	0.25%	31
2024 Q4	$557K	Buy	2,138 +4	+0.2%	+$1.19K	0.19%	35
2024 Q3	$688K	Sell	2,134 -76	-3%	-$24.9K	0.23%	29
2024 Q2	$691K	Hold	2,210	–	–	0.24%	32
2024 Q1	$628K	Hold	2,210	–	–	0.22%	40
2023 Q4	$637K	Hold	2,210	–	–	0.26%	38
2023 Q3	$594K	Hold	2,210	–	–	0.3%	34
2023 Q2	$491K	Sell	2,210 -14	-0.6%	-$3.25K	0.21%	52
2023 Q1	$538K	Sell	2,224 -1	-0%	-$245	0.28%	55
2022 Q4	$584K	Sell	2,225 -6	-0.3%	-$1.61K	0.27%	50
2022 Q3	$503K	Hold	2,231	–	–	0.38%	46
2022 Q2	$543K	Hold	2,231	–	–	0.25%	52
2022 Q1	$540K	Sell	2,231 -2,906	-57%	-$668K	0.19%	63
2021 Q4	$1.16M	Buy	5,137 +254	+5%	+$53.6K	0.43%	28
2021 Q3	$1.04M	Buy	+4,883	New	+$1.12M	0.47%	31

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

McElhenny Sheffield Capital Management's AMGN Position: Q4 2025 in Review

McElhenny Sheffield Capital Management sold out of Amgen (AMGN) in Q4 2025, closing a stake of 2,117 shares — an estimated $597K sold.

McElhenny Sheffield Capital Management first reported a position in AMGN in Q3 2021 and held it in 17 quarters. The position peaked at $1.16M in Q4 2021. 3,086 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

McElhenny Sheffield Capital Management reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
McElhenny Sheffield Capital Management sold 2,117 Amgen shares in Q4 2025, an estimated $597K.
McElhenny Sheffield Capital Management first reported a position in Amgen in Q3 2021 and held it in 17 quarters.
McElhenny Sheffield Capital Management's Amgen position peaked at $1.16M in Q4 2021.
3,086 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on McElhenny Sheffield Capital Management's 13F filing for Q4 2025, filed 21 Jan 2026.